Investing.com - Financial Markets Worldwide

AbL Diagnostics SA (ABLD)

Paris
Currency in EUR
4.50
0.00(0.00%)
Closed·
ABLD Scorecard
Full Analysis
Net income is expected to grow this year
ABLD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
4.504.50
52 wk Range
2.408.10
Key Statistics
Edit
Prev. Close
4.5
Open
4.5
Day's Range
4.5-4.5
52 wk Range
2.4-8.1
Volume
36
Average Volume (3m)
226
1-Year Change
66.67%
Book Value / Share
0.46
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABLD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 15
Analysts anticipate sales growth in the current year
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

AbL Diagnostics SA Company Profile

ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. It offers genotyping through NGS and sanger sequencing for human immunodeficiency virus, SARS CoV-2, hepatitis-C virus, mycobacterium tuberculosis, and 16S RNA; ultragene assays for viral detection of SARS CoV-2, dengue, and Zika virus; microbiological specimen transport and collection kits, which include RNA and saliva preservation, wastewater collection, and surface collection kits, as well as inactivation and preservation solution; and instrument and consumables, such as DNA/RNA extraction system, real-time PCR system, liquid handling robot, NGS library preparation system, and sanger sequencing reagents. The company also provides digital solutions comprising analysis software, data hosting, lab automation, Nadis, and SeqHepB. It sells its products directly, as well as through a network of distributors to academic clinical pathology labs, private reference labs, and researchers. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is based in Woippy, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
19
Market
France

Compare ABLD to Peers and Sector

Metrics to compare
ABLD
Peers
Sector
Relationship
P/E Ratio
254.3x17.7x12.7x
PEG Ratio
0.52−0.660.03
Price/Book
9.7x1.2x1.4x
Price / LTM Sales
12.4x0.5x1.2x
Upside (Analyst Target)
33.6%17.3%15.8%
Fair Value Upside
Unlock25.1%6.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.02%
Dividend Yield
1.11%
Industry Median 1.37%
Annualised payout
0.05
Paid unevenly
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
May 06, 2025
EPS / Forecast
-- / --
Revenue / Forecast
2.95M / --
EPS Revisions
a
a
Unlock
Last 90 days

ABLD Income Statement

FAQ

What Stock Exchange Does AbL Diagnostics Trade On?

AbL Diagnostics is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for AbL Diagnostics?

The stock symbol for AbL Diagnostics is "ABLD."

What Is the AbL Diagnostics Market Cap?

As of today, AbL Diagnostics market cap is 72.51M.

What Is AbL Diagnostics's Earnings Per Share (TTM)?

The AbL Diagnostics EPS (TTM) is 0.02.

From a Technical Analysis Perspective, Is ABLD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has AbL Diagnostics Stock Split?

AbL Diagnostics has split 1 times.

How Many Employees Does AbL Diagnostics Have?

AbL Diagnostics has 19 employees.

What is the current trading status of AbL Diagnostics (ABLD)?

As of 11 Aug 2025, AbL Diagnostics (ABLD) is trading at a price of 4.50, with a previous close of 4.50. The stock has fluctuated within a day range of 4.50 to 4.50, while its 52-week range spans from 2.40 to 8.10.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.